Skip to content
Aurenex

Biotech · Commercial

Six weeks of warning on formulary movement

Continuous payer policy monitoring turned reactive access defence into prepared evidence delivery.

The challenge

Formulary changes were discovered after they took effect, leaving no time to prepare evidence responses.

What we did

  1. 01Ingested and normalised published payer policy documents
  2. 02Detected material language changes with citation extraction
  3. 03Deployed the Market Access Agent for impact triage
  4. 04Connected alerts directly to evidence package workflows

Results

Average warning
6 weeks
Manual review
-71%
Covered lives protected
4.1M

Client: Rare disease biotech

Next step

Bring a real problem. We will bring the architecture.

Thirty minutes with our architects is usually enough to tell whether a programme is ready for agents, or whether the data foundation needs work first.

Talk to an architect
See the work